Schonfeld Strategic Advisors LLC trimmed its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 84.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,290 shares of the company's stock after selling 12,335 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Molina Healthcare were worth $667,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Wingate Wealth Advisors Inc. bought a new position in Molina Healthcare in the 4th quarter worth about $52,000. Hurley Capital LLC bought a new position in shares of Molina Healthcare in the fourth quarter worth approximately $55,000. EverSource Wealth Advisors LLC lifted its stake in shares of Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after buying an additional 88 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Molina Healthcare by 337.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after buying an additional 155 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd increased its position in shares of Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after acquiring an additional 179 shares in the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts have commented on MOH shares. Truist Financial increased their target price on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Robert W. Baird restated a "neutral" rating and set a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. UBS Group reduced their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Finally, StockNews.com upgraded shares of Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Nine research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $365.38.
Get Our Latest Analysis on MOH
Molina Healthcare Stock Down 0.6 %
MOH stock opened at $323.84 on Friday. The business's 50-day moving average price is $324.73 and its 200-day moving average price is $308.25. The stock has a market cap of $17.55 billion, a P/E ratio of 15.85, a PEG ratio of 1.06 and a beta of 0.63. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the company posted $5.73 earnings per share. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Insider Transactions at Molina Healthcare
In related news, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director now owns 11,244 shares in the company, valued at approximately $3,603,702. This represents a 5.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. This represents a 25.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 89,169 shares of company stock valued at $28,520,995 over the last 90 days. Company insiders own 1.10% of the company's stock.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.